Oragenics Files Q1 2025 10-Q Report
Ticker: OGEN · Form: 10-Q · Filed: May 9, 2025 · CIK: 1174940
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Oragenics dropped its Q1 2025 10-Q. Check financials.
AI Summary
Oragenics Inc. filed its Q1 2025 10-Q report on May 9, 2025, covering the period ending March 31, 2025. The company, based in Sarasota, FL, operates in the pharmaceutical preparations sector. This filing provides financial updates and operational details for the first quarter of the fiscal year.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Oragenics Inc. for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Oragenics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- Q1 2025 — Reporting Period (Covers the first quarter of the fiscal year.)
- 2025-03-31 — As of Date (Financial position as of the end of the first quarter.)
- 2025-05-09 — Filing Date (Date the report was submitted to the SEC.)
Key Players & Entities
- ORAGENICS INC (company) — Filer
- 0001174940 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- FL (company) — State of Incorporation
- SARASOTA (company) — City
- May 9, 2025 (date) — Filing Date
- March 31, 2025 (date) — Period End Date
FAQ
What is the primary business of Oragenics Inc.?
Oragenics Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code 2834.
When was this 10-Q report filed?
This 10-Q report was filed on May 9, 2025.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Where is Oragenics Inc. based?
Oragenics Inc. is incorporated in Florida (FL) and its business address is in Sarasota, FL.
What is the SEC file number for Oragenics Inc.?
The SEC file number for Oragenics Inc. is 001-32188.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding ORAGENICS INC (OGEN).